Crinetics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeCrinetics
Crinetics logo

Crinetics

0 followers

CRNX

Performance

About Crinetics

Crinetics Pharmaceuticals, Inc. is a biopharmaceutical company focused on endocrine diseases, developing medicines to provide effective disease control and simplified treatment options. The company emphasizes endocrine-rooted therapies, with a pipeline that includes oral SST2 agonists and ACTH antagonists targeted at conditions such as congenital adrenal hyperplasia and other endocrine disorders. Headquartered in San Diego, Crinetics operates as a specialized pharmaceutical developer and potential commercial player in the endocrinology space. The organization highlights a patient-centered approach, collaboration with advocacy groups, and a commitment to advancing endocrine care globally.

Recent News

Recent Deals

Key Team Members

Omar Hamdy, Ph.D.

Chief of Staff & Head of Portfolio Strategy

Isabel Kalofonos

Chief Commercial Officer

Stephen F. Betz, Ph.D.

Founder & Chief Scientific Officer

R. Scott Struthers, Ph.D.

Founder & Chief Executive Officer

Adriana C. Cabré

Chief Human Resources Officer

Key Facts

HQ Location

San Diego, United States

Founded

2008

Employees

201 - 500

Status

Public

Website

https://crinetics.com